IP and Innovative Companies: The Case of PerceivAI

Published on April 15, 2024

With the support of momentumPI, the innovative company PerceivAI was able to protect its intellectual property—including its trademark and technology—as it seeks to sell licenses to pharmaceutical companies.

PerceivAI - photo by Christian Dansereau

It is particularly expensive to develop treatments for certain diseases, such as Alzheimer's disease, because the effects of these treatments can vary greatly from one patient to another.

The Montreal-based startup Perceiv AI has developed a platform that helps better anticipate these effects, with the aim of accelerating the development of drugs and treatments.

[…]

Perceiv AI's business model is to sell pharmaceutical companies a license to use its service for the duration of a clinical trial.

The startup counts the Montreal-based company DalCor Pharmaceuticals among its clients. It has also formed partnerships with the major U.S. pharmaceutical companies Merck and Johnson & Johnson.

–

This content is taken from an article by InfoBref about the momentumPI service.

Curious to read more about this topic?

Visit the InfoBref website to read the full article.